BDS-I
BDS-I, a selective Kv3.4 potassium channel inhibitor from sea anemone toxin, blocks Aβ1-42-induced channel hyperactivity, caspase-3 activation, and neuronal death in PC-12 cell models. It is a valuable tool for investigating channelopathies and neuroprotective strategies in Alzheimer's disease research.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Molecular Weight
4708.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
